Archive for March 10th, 2009

FDA Approves REYATAZÃ (atazanavir Sulfate) 300 Mg Single Capsule Formulation In Combination Therapy For Adults With HIV-1 Infection Part 2

Tuesday, March 10th, 2009

Important Safety Information About REYATAZ® (atazanavir sulfate) 300 mg Capsules: REYATAZ do not answer HIV or minister to direct out endorsement HIV to others.

REYATAZ should not be taken next to the subsequent to medicine: ergot medicines, Versed®, Halcion®, Orap®, Propulsid®, Camptosar®, Crixivan®, Mevacor®, Zocor®, rifampin, St. John’s wort, AcipHex®, Nexium®, Prevacid®, [...]